Intellia Therapeutics Inc
LSE:0JBU
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Intellia Therapeutics Inc
LSE:0JBU
|
US |
|
Agilysys Inc
NASDAQ:AGYS
|
US |
|
K
|
Kawasaki Heavy Industries Ltd
SWB:KHE
|
JP |
|
Rheinmetall AG
F:RHMB
|
DE |
|
D
|
Datang International Power Generation Co Ltd
XBER:BJI
|
CN |
|
S
|
Sumitomo Mitsui Financial Group Inc
OTC:SMFNF
|
JP |
|
M
|
Merck KGaA
F:MRK
|
DE |
|
Grifols SA
MAD:GRF
|
ES |
|
A
|
Axcelis Technologies Inc
F:XXA1
|
US |
|
F
|
First Majestic Silver Corp
NYSE:AG
|
CA |
|
Haier Smart Home Co Ltd
F:HAI0
|
CN |
Shareholder Yield
Current shareholder yield for 
0JBU is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
0JBU Price
Intellia Therapeutics Inc
| Average Annual Return |
N/A
|
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -27% |
| Market Capitalization | 1.7B USD |
| Shares Outstanding | 115 830 000 |
| Percentage of Shares Shorted |
N/A
|
